Drug induced acute pancreatitis without necrosis or infection
ICD-10 K85.30 is a billable code used to indicate a diagnosis of drug induced acute pancreatitis without necrosis or infection.
K85.30 refers to drug-induced acute pancreatitis without necrosis or infection. This condition arises when certain medications trigger inflammation of the pancreas, leading to acute symptoms such as severe abdominal pain, nausea, vomiting, and elevated pancreatic enzymes. The pancreas, located behind the stomach, plays a crucial role in digestion and blood sugar regulation. In drug-induced cases, the inflammation is typically reversible upon discontinuation of the offending agent. The disease progression can vary, with some patients experiencing mild symptoms that resolve quickly, while others may develop more severe manifestations requiring hospitalization. Diagnostic considerations include a thorough patient history to identify potential drug exposures, laboratory tests to assess pancreatic enzyme levels, and imaging studies to rule out other causes of abdominal pain. Clinicians must also consider the timing of symptom onset in relation to medication use, as this can aid in establishing a causal link.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K85.30 covers acute pancreatitis specifically induced by drugs, excluding cases with necrosis or infection. Common drugs associated include certain diuretics, antiepileptics, and antibiotics.
K85.30 should be used when acute pancreatitis is directly linked to drug exposure without evidence of necrosis or infection, differentiating it from idiopathic or alcohol-induced cases.
Documentation should include a comprehensive medication history, clinical presentation details, laboratory results indicating elevated pancreatic enzymes, and imaging studies that exclude other causes.
